EUCODIS Bioscience is an experienced enzyme engineering company founded in 2007. The company's slogan "Pioneering enzyme engineering for industry leaders in chemicals, pharmaceuticals, food, feed, and cosmetics" captures its focus on providing high-performing enzymes to industrial customers. EUCODIS Bioscience serves leaders in the chemical, pharmaceutical, food, feed, and cosmetics industries, making it a key player in the Biopharma, Biotechnology, Medical Devices, and Wellness Beauty sectors. The company received a significant €2.50MConvertible Note investment on 31 January 2013 from Arax Capital Partners. This investment underscores the confidence of prominent investors in EUCODIS Bioscience's capabilities and potential for growth in the enzyme engineering space.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Convertible Note | €2.50M | 1 | 31 Jan 2013 | |
Venture Round | €626.00K | 1 | 17 Sep 2012 | |
Series B | $2.70M | 3 | Wiener Wachstumsfonds, PONTIS Venture Partners Management | 17 Mar 2010 |
Venture Round | $5.91M | 5 | PONTIS Venture Partners Management, Gamma Capital Partners | 20 Nov 2007 |
No recent news or press coverage available for EUCODIS Bioscience.